• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Avel eCare Launches Clinical Workflow Platform for Telemedicine Services

by Fred Pennic 05/23/2024 Leave a Comment

Avel eCare Launches Clinical Workflow Platform for Telemedicine Services

What You Should Know:  - Avel eCare, a leading provider of clinician-to-clinician telemedicine services, has announced the launch of Avel eSync.  - The innovative platform is designed to revolutionize telemedicine by streamlining workflows and empowering healthcare organizations to seamlessly integrate these services into their operations. Optimizing the Clinician Experience Avel eSync's core strength lies in its advanced workflow capabilities. This clinician-centric
Read More

Click Therapeutics Acquires Better Therapeutics, Expands into Obesity and Cardiometabolic Disease

by Fred Pennic 05/22/2024 Leave a Comment

Click Therapeutics Acquires Better Therapeutics, Expands into Obesity and Cardiometabolic Disease

What You Should Know:  - Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.  - Click's expansion into cardiometabolic disease follows successful DTx development efforts in other areas, including migraine prevention, depression, schizophrenia, and opioid use disorder.   Strengthening the DTx Pipeline The acquisition includes several key assets from Better
Read More

Virtual Reality Relief for Workers’ Compensation: AppliedVR Launches RelieVRx® Program

by Jasmine Pennic 05/22/2024 Leave a Comment

AppliedVR Releases Clinical Trial Results from In-Home Virtual Reality Program for Chronic Lower Back Pain

What You Should Know:  - AppliedVR, a leader in immersive therapeutic solutions, has announced the launch of their flagship product, RelieVRx®, into the workers' compensation market. This FDA-authorized virtual reality (VR) program is the first of its kind to offer comprehensive, non-pharmacological treatment for chronic lower back pain (CLBP - AppliedVR's RelieVRx® program signifies a significant advancement in pain management for workers' compensation claims.   A
Read More

COTA and FDA Extend Collaboration to Advance Use of Real-World Data in Cancer Research

by Jasmine Pennic 05/22/2024 Leave a Comment

COTA and FDA Extend Collaboration to Advance Use of Real-World Data in Cancer Research

What You Should Know:  - COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the U.S. Food and Drug Administration's (FDA) Oncology Center of Excellence (OCE).  - The five-year extension builds upon a successful partnership established in 2018 and signifies a continued commitment to utilizing real-world data (RWD) to enhance cancer treatment and regulatory decisions. Building on a Successful
Read More

Twin Health Unveils Digital Twin AI for Weight Loss with GLP-1 Elimination

by Syed Hamza Sohail 05/22/2024 Leave a Comment

Twin Health Unveils Digital Twin AI for Weight Loss with GLP-1 Elimination

What You Should Know: -       Today, Twin Health announced it is extending its whole body digital twin AI platform, proven to help members achieve remission of type 2 diabetes and eliminate medications, to address the challenge of obesity and weight loss. -       Twin’s Healthy Weight solution combines digital twin AI and compassionate clinical care to help members achieve a healthy weight that they can sustain
Read More

GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

by Jasmine Pennic 05/22/2024 Leave a Comment

GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

What You Should Know:  - GoodRx, a leading platform for prescription medication savings, announced today it's offering significant discounts of up to 43% on fertility treatments based on the best available GoodRx price. This move aims to help families and individuals manage the often-prohibitive costs associated with in vitro fertilization (IVF) and other fertility treatments. - By offering substantial discounts and educational resources, GoodRx is committed to making fertility care
Read More

Wysa Awarded $3.4M Grant to Develop Personalized Mental Health Support for Chronic Pain

by Fred Pennic 05/22/2024 Leave a Comment

Wysa Secures $20M for AI-Powered Mental Health Chatbot

What You Should Know:  - Wysa, a leading provider of digital mental health platforms, has been selected as a sub-awardee for a $3.4M grant from the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH).  - The 4-year project, led by Washington University in St. Louis with Duke University as another sub-awardee, aims to develop personalized pathways for individuals managing mental health conditions alongside chronic pain. Just-in-Time
Read More

WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device

by Fred Pennic 05/21/2024 Leave a Comment

WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA 510(k) Cleared 6-Lead ECG Device

What You Should Know:  - WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.  - The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.  Tackling the
Read More

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

by Fred Pennic 05/21/2024 Leave a Comment

Sanofi, Formation Bio, OpenAI Partner on AI-Powered Drug Discovery

What You Should Know:  - Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration.  The first-of-its-kind partnership in the pharma and life sciences industries aims to leverage AI to accelerate drug development and bring new medicines to patients faster. - Sanofi, Formation Bio, and OpenAI believe this collaboration will be
Read More

Revolutionizing Medical AI: John Snow Labs’ LLMs Outperforms GPT-4, Med-PaLM2

by Jasmine Pennic 05/21/2024 Leave a Comment

Revolutionizing Medical AI: John Snow Labs' LLMs Outperforms GPT-4, Med-PaLM2

What You Should Know:  - John Snow Labs, a leader in AI for healthcare, has announced a significant breakthrough in medical Large Language Model (LLM) accuracy. Their models have achieved state-of-the-art (SOTA) performance on industry benchmarks, surpassing hundreds of competing models. - John Snow Labs' Healthcare NLP & LLM subscription provides access to their state-of-the-art models, along with ongoing updates and new releases. This ensures customers stay ahead of the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 130
  • Go to page 131
  • Go to page 132
  • Go to page 133
  • Go to page 134
  • Interim pages omitted …
  • Go to page 728
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |